{"schema_version":"secwatch.filing_event.v1","accession":"0001079973-24-001110","form_type":"8-K","ticker":"LCTC","cik":"0001493137","company_name":"Lifeloc Technologies, Inc","filed_at":"2024-07-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.232265+00:00","generated_at":"2026-05-31T15:57:12.592084+00:00","sec_items":["1.01","3.02","5.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Lifeloc raises $798K via private placement, appoints new director, secures $750K credit line","bullets":["Issued 210,000 shares at $3.80 to EDCO Partners, raising $798K; EDCO now holds 77.5% of common stock.","Robert Greenlee resigned from board; replaced by Adam Kashenberg, CEO of Colorado Biolabs, effective July 23.","Obtained $750K line of credit from Citywide Banks on July 19, 2024.","Plans beta testing of saliva THC test (SpinDx) in 2024, targeting commercial launch in 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001079973-24-001110","json":"https://secwatch.observer/filing/0001079973-24-001110.json","markdown":"https://secwatch.observer/filing/0001079973-24-001110.md","text":"https://secwatch.observer/filing/0001079973-24-001110.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1493137/000107997324001110/0001079973-24-001110-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1493137/000107997324001110/lctc_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T15:57:12.592084+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8aeb297993","claim":"Robert Greenlee resigned as Director at Lifeloc Technologies, Inc.","evidence_excerpt":"On July 22, 2024, Robert Greenlee notified the Company by letter of his resignation from the board of directors (the “Board”) of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1493137/000107997324001110/0001079973-24-001110-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"b5efad48aa","claim":"Adam Kashenberg was appointed as Director at Lifeloc Technologies, Inc.","evidence_excerpt":"On July 23, 2024, in accordance with the Company’s Amended and Restated Bylaws (the “Bylaws”), the Board appointed Adam Kashenberg to fill the vacancy on the Board and on the Company’s audit committee created by Mr. Greenlee’s resignation.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1493137/000107997324001110/0001079973-24-001110-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}